Freestone Grove Partners’s Innoviva INVA Stock Holding History
Bought
Maintained
Sold
Other funds holding INVA
VPM
VCM
SCM
SFM
Freestone Grove Partners's INVA Position: Q1 2026 in Review
Freestone Grove Partners reduced its Innoviva (INVA) stake by 11% in Q1 2026, selling an estimated $212K and leaving 81,846 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #377.
Freestone Grove Partners first reported a position in INVA in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.22M in Q3 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.
- Freestone Grove Partners held 81,846 shares of Innoviva worth $1.91M as of Q1 2026.
- Freestone Grove Partners sold 9,827 Innoviva shares in Q1 2026, an estimated $212K.
- Innoviva made up 0.01% of Freestone Grove Partners's portfolio in Q1 2026, its #377 holding.
- Freestone Grove Partners first reported a position in Innoviva in Q4 2024 and has held it in 6 quarters since.
- Freestone Grove Partners's Innoviva position peaked at $3.22M in Q3 2025.
- 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.